Skip Header

 
Contribute Send feedback
Read comments (1) or add your own

Reviewed, UniProtKB/Swiss-Prot O95684 (FR1OP_HUMAN)

Last modified June 16, 2009. Version 55. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (6) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    FGFR1 oncogene partner
Gene names
Name: FGFR1OP
Synonyms: FOP
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length399 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Required for anchoring microtubules to the centrosomes. Ref.6

Subunit structure

Homodimer. Part of a ternary complex that contains CEP350, FGFR1OP and MAPRE1. Interacts directly with CEP350 and MAPRE1. Ref.6 Ref.10

Subcellular location

Centrosome. Note: Associated with gamma-tubulin. Ref.6 Ref.10 Ref.4

Tissue specificity

Ubiquitous. Highly expressed in heart, liver, muscle, kidney, intestine, colon, adrenal gland, prostate, testis, and pancreas. Ref.1

Involvement in disease

A chromosomal aberration involving FGFR1OP may be a cause of stem cell myeloproliferative disorder (MPD). Translocation t(6;8)(q27;p11) with FGFR1. MPD is characterized by myeloid hyperplasia, eosinophilia and T-cell or B-cell lymphoblastic lymphoma. In general it progresses to acute myeloid leukemia. The fusion proteins FGFR1OP-FGFR1 or FGFR1-FGFR1OP may exhibit constitutive kinase activity and be responsible for the transforming activity.

Sequence similarities

Contains 1 LisH domain.

Ontologies

Keywords
   Coding sequence diversityAlternative splicing
Chromosomal rearrangement
Polymorphism
   PTMPhosphoprotein
   Technical term3D-structure
Gene Ontology (GO)
   Biological processmicrotubule anchoring

Inferred from electronic annotation. Source: InterPro

positive regulation of cell proliferation Ref.1

Traceable author statement. Source: ProtInc

   Cellular componentcentrosome

Inferred from electronic annotation. Source: UniProtKB-SubCell

Complete GO annotation...

Alternative products

This entry describes 3 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: O95684-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: O95684-2)

Also known as: B;

The sequence of this isoform differs from the canonical sequence as follows:
     174-193: Missing.
Isoform 3 (identifier: O95684-3)

The sequence of this isoform differs from the canonical sequence as follows:
     1-249: Missing.
     376-399: LDDLTQDLTVSQLSDVADYLEDVA → TITQLECLLSIGALHFKNTADIF

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 399399FGFR1 oncogene partner
PRO_0000233293

Regions

Domain70 – 10233LisH

Sites

Site173 – 1742Breakpoint for translocation to form FGFR1OP-FGFR1 or FGFR1-FGFR1OP fusion proteins

Amino acid modifications

Modified residue1561Phosphoserine Ref.5 Ref.7 Ref.8
Modified residue1601Phosphoserine Ref.5 Ref.7 Ref.8
Modified residue2021Phosphoserine Ref.8
Modified residue2541Phosphoserine Ref.8
Modified residue3371Phosphotyrosine By similarity

Natural variations

Alternative sequence1 – 249249Missing in isoform 3.
VSP_018119
Alternative sequence174 – 19320Missing in isoform 2.
VSP_018120
Alternative sequence376 – 39924LDDLT…LEDVA → TITQLECLLSIGALHFKNTA DIF in isoform 3.
VSP_018121
Natural variant2711K → N: dbSNP rs17856382. Ref.3
VAR_051000

Experimental info

Mutagenesis741V → F: Abolishes homodimerization and leads to aggregation. Ref.10
Sequence conflict631K → R in AAH11902. Ref.3

Secondary structure

............. 399
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 [UniParc].

Last modified May 1, 1999. Version 1.
Checksum: 7A4B65F627B9D272

FASTA39943,065
        10         20         30         40         50         60 
MAATAAAVVA EEDTELRDLL VQTLENSGVL NRIKAELRAA VFLALEEQEK VENKTPLVNE 

        70         80         90        100        110        120 
SLKKFLNTKD GRLVASLVAE FLQFFNLDFT LAVFQPETST LQGLEGRENL ARDLGIIEAE 

       130        140        150        160        170        180 
GTVGGPLLLE VIRRCQQKEK GPTTGEGALD LSDVHSPPKS PEGKTSAQTT PSKIPRYKGQ 

       190        200        210        220        230        240 
GKKKTSGQKA GDKKANDEAN QSDTSVSLSE PKSKSSLHLL SHETKIGSFL SNRTLDGKDK 

       250        260        270        280        290        300 
AGLCPDEDDM EGDSFFDDPI PKPEKTYGLR KEPRKQAGSL ASLSDAPPLK SGLSSLAGAP 

       310        320        330        340        350        360 
SLKDSESKRG NTVLKDLKLI SDKIGSLGLG TGEDDDYVDD FNSTSHRSEK SEISIGEEIE 

       370        380        390 
EDLSVEIDDI NTSDKLDDLT QDLTVSQLSD VADYLEDVA 

« Hide

Isoform 2 (B).

Checksum: D784C5E935B62312
Show »

FASTA37940,907
Isoform 3.

Checksum: A5D7366B2281F755
Show »

FASTA14916,106

References

« Hide 'large scale' references
[1]"The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1."
Popovici C., Zhang B., Gregoire M.-J., Jonveaux P., Lafage-Pochitaloff M., Birnbaum D., Pebusque M.-J.
Blood 93:1381-1389(1999) [PubMed: 9949182] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHROMOSOMAL TRANSLOCATION WITH FGFR1, ALTERNATIVE SPLICING, TISSUE SPECIFICITY.
[2]"The DNA sequence and analysis of human chromosome 6."
Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. expand/collapse author list , Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V., Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J., Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J., French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.
Nature 425:805-811(2003) [PubMed: 14574404] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[3]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), VARIANT ASN-271.
Tissue: Brain and Muscle.
[4]"Proteomic characterization of the human centrosome by protein correlation profiling."
Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.
Nature 426:570-574(2003) [PubMed: 14654843] [Abstract]
Cited for: SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY.
[5]"Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry."
Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M., Peters E.C.
Anal. Chem. 76:2763-2772(2004) [PubMed: 15144186] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156 AND SER-160, MASS SPECTROMETRY.
Tissue: T-cell.
[6]"A complex of two centrosomal proteins, CAP350 and FOP, cooperates with EB1 in microtubule anchoring."
Yan X., Habedanck R., Nigg E.A.
Mol. Biol. Cell 17:634-644(2006) [PubMed: 16314388] [Abstract]
Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH MAPRE1 AND CEP350.
[7]"Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry."
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156 AND SER-160, MASS SPECTROMETRY.
[8]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156; SER-160; SER-202 AND SER-254, MASS SPECTROMETRY.
[9]Colinge J., Superti-Furga G., Bennett K.L.
Submitted (OCT-2008) to UniProtKB
Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY.
[10]"Structure of the N-terminal domain of the FOP (FGFR1OP) protein and implications for its dimerization and centrosomal localization."
Mikolajka A., Yan X., Popowicz G.M., Smialowski P., Nigg E.A., Holak T.A.
J. Mol. Biol. 359:863-875(2006) [PubMed: 16690081] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 54-134, MUTAGENESIS OF VAL-74, SUBCELLULAR LOCATION, SUBUNIT.
+Additional computationally mapped references.

Cross-references

Sequence databases

Y18046 mRNA. Translation: CAA77020.1.
Z94721 Genomic DNA. Translation: CAI19642.1.
Z94721 Genomic DNA. Translation: CAI19643.1.
BC011902 mRNA. Translation: AAH11902.1.
BC037785 mRNA. Translation: AAH37785.1.
IPIIPI00013076.
IPI00305013.
IPI00641007.
RefSeqNP_008976.1.
NP_919410.1.
UniGeneHs.487175

3D structure databases

EntryMethodResolution (Å)ChainPositionsPDBsum
2D68X-ray1.60A/B54-134[»]
ModBaseSearch...

PTM databases

PhosphoSiteO95684.

Proteomic databases

PRIDEO95684.

Genome annotation databases

EnsemblENSG00000213066. Homo sapiens. [Contig view]
GeneID11116.
KEGGhsa:11116.

Organism-specific databases

GeneCardsGC06P167384.
H-InvDBHIX0078235.
HGNCHGNC:17012. FGFR1OP.
MIM605392. gene.
PharmGKBPA134941638.
GenAtlasSearch...

Phylogenomic databases

HOGENOMO95684.
HOVERGENO95684.
OMAO95684. HETKIGS.

Gene expression databases

ArrayExpressO95684.
BgeeO95684.
CleanExHS_FGFR1OP.
GermOnlineENSG00000112486. Homo sapiens.

Family and domain databases

InterProIPR018993. FOP_dimerisation-dom_N.
IPR006594. LisH_dimerisation.
[Graphical view]
PfamPF09398. FOP_dimer. 1 hit.
[Graphical view]
SMARTSM00667. LisH. 1 hit.
[Graphical view]
PROSITEPS50896. LISH. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio42246.
SOURCESearch...

Entry information

Entry nameFR1OP_HUMAN
AccessionPrimary (citable) accession number: O95684
Secondary accession number(s): Q49AI0, Q5R3F6, Q96EW1
Entry history
Integrated into UniProtKB/Swiss-Prot: May 2, 2006
Last sequence update: May 1, 1999
Last modified: June 16, 2009
This is version 55 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

Human chromosome 6

Human chromosome 6: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents